Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
568.09
573.28
512.35
512.12
430.90
321.16
340.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
568.09
573.28
512.35
512.12
430.90
321.16
340.14
Raw Material Cost
185.66
192.71
192.99
190.78
140.41
95.12
98.85
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
26.49
38.79
40.68
18.42
5.50
7.51
21.58
Selling and Distribution Expenses
311.77
316.09
289.89
306.10
224.12
181.84
192.30
Other Expenses
-1.44
-2.48
-2.72
0.54
0.97
0.37
-1.05
Total Expenditure (Excl Depreciation)
509.54
522.74
496.33
520.74
379.71
288.12
302.20
Operating Profit (PBDIT) excl Other Income
58.5
50.5
16
-8.6
51.2
33
37.9
Other Income
-2.04
-3.35
-2.29
-9.77
-4.44
3.18
0.07
Operating Profit (PBDIT)
103.52
96.74
71.09
43.01
85.43
64.87
68.34
Interest
26.49
38.79
40.68
18.42
5.50
7.51
21.58
Exceptional Items
-4.32
-60.74
-94.16
-152.21
-33.62
-12.80
-6.75
Gross Profit (PBDT)
382.43
380.57
319.35
321.33
290.49
226.04
241.29
Depreciation
47.01
49.55
57.37
61.40
38.68
28.64
30.32
Profit Before Tax
25.71
-52.34
-121.11
-189.03
7.62
15.91
9.69
Tax
-1.56
-5.29
0.09
-44.37
-1.97
1.19
1.58
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
22.73
-36.12
-96.74
-103.92
19.38
10.52
7.11
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
22.73
-36.12
-96.74
-103.92
19.38
10.52
7.11
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.54
-10.92
-24.46
-40.73
-9.79
-1.69
-0.55
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
27.27
-47.05
-121.20
-144.65
9.59
8.83
6.56
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
184.10
147.94
173.59
325.24
458.92
142.24
142.98
Earnings per share (EPS)
0.33
-0.56
-2.49
-2.59
0.33
0.08
-0.01
Diluted Earnings per share
0.33
-0.56
-2.49
-2.59
0.33
0.08
-0.01
Operating Profit Margin (Excl OI)
10.31%
8.82%
3.13%
-1.68%
11.88%
10.29%
11.16%
Gross Profit Margin
12.8%
-0.49%
-12.44%
-24.92%
10.75%
13.87%
11.76%
PAT Margin
4.0%
-6.3%
-18.88%
-20.29%
4.5%
3.27%
2.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -0.91% vs 11.91% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 158.09% vs 61.22% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 5.49% vs 36.38% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -31.70% vs -4.67% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Bioventus, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
568.09
0.00
568.09
Other Operating Income
0.00
0.00
0.00
Total Operating income
568.09
0.00
568.09
Raw Material Cost
185.66
0.13
185.53
142,715.38%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
26.49
10.28
16.21
157.68%
Selling and Distribution Expenses
311.77
8.93
302.84
3,391.27%
Other Expenses
-1.44
9.39
-10.83
-115.34%
Total Expenditure (Excl Depreciation)
509.54
113.27
396.27
349.85%
Operating Profit (PBDIT) excl Other Income
58.55
-113.27
171.82
151.69%
Other Income
-2.04
11.77
-13.81
-117.33%
Operating Profit (PBDIT)
103.52
-101.37
204.89
202.12%
Interest
26.49
10.28
16.21
157.68%
Exceptional Items
-4.32
0.00
-4.32
Gross Profit (PBDT)
382.43
-0.13
382.56
294,276.92%
Depreciation
47.01
0.13
46.88
36,061.54%
Profit Before Tax
25.71
-111.78
137.49
123.00%
Tax
-1.56
0.00
-1.56
Provisions and contingencies
0
0
0.00
Profit After Tax
22.73
-111.78
134.51
120.33%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
22.73
-111.78
134.51
120.33%
Share in Profit of Associates
0
0
0.00
Minority Interest
4.54
0.00
4.54
Other related items
0.00
0.00
0.00
Consolidated Net Profit
27.27
-111.78
139.05
124.40%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
184.10
115.62
68.48
59.23%
Earnings per share (EPS)
0.33
-2.83
3.16
111.66%
Diluted Earnings per share
0.33
-2.83
3.16
111.66%
Operating Profit Margin (Excl OI)
10.31%
0.00%
0.00
10.31%
Gross Profit Margin
12.80%
0.00%
0.00
12.80%
PAT Margin
4.00%
0.00%
0.00
4.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 56.81 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -0.91% vs 11.91% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 2.73 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 158.09% vs 61.22% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.56 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 5.49% vs 36.38% in Dec 2024
Annual - Interest
Interest 2.65 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -31.70% vs -4.67% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.31%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






